Mirae Cell Bio

Mirae Cell Bio is a next-generation cell therapy development company. We are developing MSC (Mesenchymal Stem Cell) cell therapy using ENS (Epithelial-mesenchymal transition based Natural Selection) platform technology. We also possess a GMP certified medical therapy manufacturing facility used for the production of cell therapy agents. Our phase 2 drug candidate, designated as an orphan drug in Korea, is the first-in-class drug targeting interstitial cystitis.
*MSC: Also known as Multipotent stromal cells that can differentiate into a variety of cell types
*ENS: By recreating human development in vitro without chemical treatment, differentiation is induced by natural selection without cell damage.

---

URL: http://www.miraecellbio.com/

Location: Korea